NewsRoom
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and […]
申し訳ありません、このコンテンツはただ今 中文 のみです。 For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
申し訳ありません、このコンテンツはただ今 中文 のみです。 For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing Chime Biologics and Waterstone Pharmaceuticals […]
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Bridges Innovation and Collaboration at Europe-China Biotech Business Forum 2024 November 4, Stockholm, Sweden – Chime Biologics, a leading […]
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing October 28, 2024, Shanghai, […]
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation Not available.
申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics SEATTLE, Oct. 9, 2024 /PRNewswire/ — Arbele, a leading innovator […]
